It is alleged in this complaint that Decision Diagnostics made misleading and false statements to the market. Decision Diagnostics failed to develop a COVID-19 test that was viable in any form, and failed to develop one that could detect the COVID-19 virus within one minute. Decision Diagnostics was not capable of meeting the U.S. Food and Drug Administration’s EUA testing requirements in regard to its purported COVID-19 test. Despite Decision Diagnostic’s inability to meet these FDA requirements, the Company touted an unrealistic time to market for its tests. Decision Diagnostic’s public statements were materially misleading and false throughout the class period, based on these facts.
Decision Diagnostics Corp.
Investors that purchased the Company’s securities and have suffered a loss, please fill in transaction information below, or email to info@portnoylaw.com.
There is no cost or obligation associated with submitting your information. If you are a shareholder who suffered a loss, please submit your contact information and purchase information to participate in the putative class action.
We also encourage you to contact Lesley F. Portnoy of The Portnoy Law Firm, at 310.692.8883, to discuss your rights free of charge. You can also reach us through the firm’s website at www.portnoylaw.com, or by email at info@portnoylaw.com.
If you choose to take no action, you can remain an absent class member.
Joining the case through the Portnoy Law website enables investors to learn about their legal claims and take an active role in recovering their losses.
The Portnoy Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
CONTACT:
Portnoy Law Firm
Lesley F. Portnoy, Esq.,
www.portnoylaw.com
Office: 310.692.8883
1800 Century Park East, Suite 600
Los Angeles, CA 90067
info@portnoylaw.com
